The chairman of Novo Nordisk and six other independent board members quit on Tuesday after a dispute with the company's controlling shareholder, as the drugmaker looks to revive sales of its blockbuster weight-loss drug Wegovy.

Another name in the AI story reporting in the week ahead is Advanced Micro Devices (AMD), which has also hit fresh highs on the back of recent deals with other big-name tech companies. Fellow chipmaker Nvidia (NVDA) has also announced a number of tech deals,

Novo Nordisk cuts over 800 jobs in Plainsboro, part of a global restructuring under the new CEO, reflecting a troubling trend of layoffs across New Jersey's healthcare and hospitality sectors.

Novo Nordisk Shares Fell 5.6% After President Trump Commented on Future Price Cuts for Weight Loss Drugs. Should Investors Be Worried? While that could be an issue for Novo Nordisk, it should find a way to navigate ongoing price negotiations.